| Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension | Journal of Hepatology | 2015 | 1.9K |
| Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease | Gastroenterology | 2015 | 1.5K |
| NAFLD: a multisystem disease | Journal of Hepatology | 2015 | 1.3K |
| Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up | Hepatology | 2015 | 1.2K |
| Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States | Gastroenterology | 2015 | 1.1K |
| EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis | Journal of Hepatology | 2015 | 1.1K |
| Global distribution and prevalence of hepatitis C virus genotypes | Hepatology | 2015 | 1.1K |
| Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target | American Journal of Gastroenterology | 2015 | 1K |
| Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis | Gastroenterology | 2015 | 1K |
| The global burden of IBD: from 2015 to 2025 | Nature Reviews Gastroenterology and Hepatology | 2015 | 985 |
| Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus | Hepatology | 2015 | 968 |
| EASL Recommendations on Treatment of Hepatitis C 2015 | Journal of Hepatology | 2015 | 942 |
| ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes | American Journal of Gastroenterology | 2015 | 889 |
| Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial | Gastroenterology | 2015 | 857 |
| Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies | Clinical Gastroenterology and Hepatology | 2015 | 804 |
| Epidemiology and risk factors for IBD | Nature Reviews Gastroenterology and Hepatology | 2015 | 783 |
| Genetic Landscape and Biomarkers of Hepatocellular Carcinoma | Gastroenterology | 2015 | 695 |
| Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease | Journal of Hepatology | 2015 | 667 |
| Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management | Journal of Hepatology | 2015 | 626 |
| Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease | Gastroenterology | 2015 | 622 |
| Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States | Gastroenterology | 2015 | 593 |
| Overview of microRNA biology | Seminars in Liver Disease | 2015 | 584 |
| EASL Clinical Practice Guidelines: Autoimmune hepatitis | Journal of Hepatology | 2015 | 580 |
| Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease | Gastroenterology | 2015 | 573 |
| Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis | Gastroenterology | 2015 | 571 |
